Cargando…

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal cancer with a dismal five-year survival rate of 11%. Despite remarkable advancements in cancer therapeutics, PDAC patients rarely benefit from it due to insurmountable treatment resistance. Notably, PDAC is pathologically characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Sheng-Kai, Jadhao, Mahendra, Liao, Wei-Ting, Chang, Wen-Tsan, Hung, Chun-Tzu, Chiu, Chien-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589289/ https://www.ncbi.nlm.nih.gov/pubmed/36299300 http://dx.doi.org/10.3389/fmolb.2022.1020888

Ejemplares similares

NCOA4-Mediated Ferritinophagy: A Vicious Culprit in COVID-19 Pathogenesis?
por: Jia, Fengju, et al.
Publicado: (2021)

An Extended C-Terminus, the Possible Culprit for Differential Regulation of 5-Aminolevulinate Synthase Isoforms
por: Hunter, Gregory A., et al.
Publicado: (2022)

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
por: Lin, Xinqing, et al.
Publicado: (2020)

Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts
por: Wang, Hufei, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

GWAS-Top Polymorphisms Associated With Late-Onset Alzheimer Disease in Brazil: Pointing Out Possible New Culprits Among Non-Coding RNAs
por: Kretzschmar, Gabriela Canalli, et al.
Publicado: (2021)

Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study
por: Chen, Shaohua, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

The progress of microenvironment-targeted therapies in brain metastases
por: Long, Lifu, et al.
Publicado: (2023)

Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2020)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Unveiling Tumor Microenvironment Interactions Using Zebrafish Models
por: Loveless, Reid, et al.
Publicado: (2021)

The Role of Tumour Metabolism in Cisplatin Resistance
por: Wang, Lude, et al.
Publicado: (2021)

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
por: Henke, Erik, et al.
Publicado: (2020)

Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2021)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics
por: Shi, Rongchen, et al.
Publicado: (2023)

Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor Response
por: Goode, Emily F., et al.
Publicado: (2021)

Transforming growth factor-β in tumour development
por: Trelford, Charles B., et al.
Publicado: (2022)

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment
por: Bao, Qianqian, et al.
Publicado: (2022)

Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
por: Khan, Safir Ullah, et al.
Publicado: (2023)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
por: Martins-Lima, Cláudia, et al.
Publicado: (2023)

The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023)

Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation
por: Xu, Fei, et al.
Publicado: (2021)

Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19
por: Yang, Yun, et al.
Publicado: (2021)

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types
por: Wu, Yuliang, et al.
Publicado: (2022)

The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors
por: Zhang, Zhizhu, et al.
Publicado: (2021)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors
por: Cheng, Xiaoliang, et al.
Publicado: (2020)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma
por: Dai, Zili, et al.
Publicado: (2021)

Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022)

Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures
por: Zhang, Congjun, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data
por: Baldi, Salem, et al.
Publicado: (2022)

FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
por: Chi, Hao, et al.
Publicado: (2023)

Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma
por: Ying, Haoxuan, et al.
Publicado: (2021)

CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Huang, Huimin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0bjrsvv8hljvf2a90qf6a9nrju